Search

Stryker Corp

Gesloten

SectorGezondheidszorg

273.92 -2.02

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

273.92

Max

276.83

Belangrijke statistieken

By Trading Economics

Inkomsten

531M

1.3B

Verkoop

569M

6.6B

K/W

Sectorgemiddelde

29.24

56.432

EPS

3.69

Dividendrendement

1.26

Winstmarge

19.366

Werknemers

56,000

EBITDA

266M

1.6B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+34.94% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

1.26%

2.27%

Volgende Winsten

29 okt 2026

Volgende dividenddatum

30 okt 2026

Volgende Ex Dividend datum

29 sep 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-21B

108B

Vorige openingsprijs

275.94

Vorige sluitingsprijs

273.92

Nieuwssentiment

By Acuity

56%

44%

262 / 339 Rangschikking in Healthcare

Stryker Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 sep 2026, 23:02 UTC

Stryker Corp is seeing a notable increase in after-market trading, gaining ground since Friday's close and reflecting significant upward movement.

17 sep 2026, 20:07 UTC

News

Stryker Corporation's stock fell amid scrutiny over ongoing manufacturing issues, resulting in a loss of over $10 billion in market capitalization.

16 sep 2026, 23:01 UTC

Correlated Moves

Stryker Corp is experiencing a modest decline in after-market trading, retracing significantly after peaking post-close amid broader market fluctuations.

15 sep 2026, 23:21 UTC

Stryker Corp shares are lower in after-market hours, reflecting broader market trends as rising Treasury yields pressure equities amid rate hike expectations.

14 sep 2026, 20:03 UTC

News

Stryker Corp shares are higher today, responding positively despite Citigroup lowering its price target to $360 while maintaining a "buy" rating.

11 sep 2026, 22:01 UTC

Stryker Corp shares are lower in after-market trading. The decline follows a drop in the Michigan Consumer Sentiment Index, reflecting consumer concerns about inflation.

10 sep 2026, 20:03 UTC

Macro Event
News

Stryker Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in share price amid ongoing manufacturing issues.

9 sep 2026, 20:07 UTC

News

Stryker Corp shares are declining amid a securities fraud investigation and a lowered price target of $348 from Wells Fargo.

8 sep 2026, 23:06 UTC

Stryker Corp. shares are higher in after-market trading, following seven consecutive sessions of declines amid rising expectations for a Federal Reserve interest rate hike.

4 sep 2026, 20:07 UTC

Stryker Corp shares are lower today, marking six consecutive sessions of declines. The stock remains significantly below its 20-day moving average.

3 sep 2026, 19:36 UTC

Stryker Corp shares are lower today, continuing a four-session decline. The stock remains significantly below its 20-day moving average amid broader market trends.

2 sep 2026, 22:16 UTC

Shares of Stryker Corp are trading higher in after-market hours, following a session peak. Broader market concerns include rising oil prices and inflation risks.

1 sep 2026, 23:26 UTC

Stryker Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. Rising oil prices are noted as broader market context.

31 aug 2026, 20:03 UTC

Stryker Corp shares are lower amid broader market pressures from Jackson Hole remarks on inflation and potential interest rate hikes. No specific company news identified.

28 aug 2026, 20:02 UTC

Stryker Corp shares are higher today, continuing an upward trend since Thursday's close, despite earlier session declines. No specific news was identified.

27 aug 2026, 21:02 UTC

Correlated Moves

Shares rise in after-market hours, rebounding from three lower sessions.

26 aug 2026, 20:08 UTC

Stryker Corp shares are lower as inflation data shows consumer prices rose more than expected, influencing broader market trends. No specific company news was identified.

25 aug 2026, 23:36 UTC

Stryker Corp shares are lower in after-market trading, positioned below their 20-day moving average and near the lower end of their one-month range.

24 aug 2026, 20:06 UTC

News

Stryker Corp received a $100 million contract modification from the U.S. Department of Defense, but shares are trading lower amid rising oil prices and geopolitical tensions.

21 aug 2026, 19:53 UTC

News

Stryker Corp shares are higher as insider selling by Ronda E. Stryker is offset by strong financial metrics, including a 9.42% revenue growth rate.

20 aug 2026, 20:02 UTC

News

Stryker Corp shares are lower today, reflecting broader market pressures following Walmart's disappointing earnings and a 3.40% decline since Wednesday.

19 aug 2026, 20:02 UTC

News

Stryker Corp received a $100 million contract modification from the Defense Logistics Agency, boosting shares during Wednesday's trading session.

18 aug 2026, 19:35 UTC

Stryker Corp is advancing today, driven by gains in the Health Care Equipment sub-sector. Earlier, shares peaked before pulling back slightly.

17 aug 2026, 19:51 UTC

Stryker Corp shares are lower today, continuing a decline influenced by weakness in the Health Care Equipment sector. No specific news was identified.

14 aug 2026, 19:56 UTC

Stryker Corp shares are lower amid broader market sentiment following a surprise drop in U.S. retail sales for July. The stock has seen lower closes recently.

13 aug 2026, 20:06 UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

12 aug 2026, 19:16 UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

11 aug 2026, 23:26 UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

10 aug 2026, 23:06 UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

7 aug 2026, 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

Peer Vergelijking

Prijswijziging

Stryker Corp Prognose

Koersdoel

By TipRanks

34.94% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 371.235 USD  34.94%

Hoogste 420 USD

Laagste 317 USD

Gebaseerd op 18 Wall Street-analisten die 12-maands prijsdoelen bieden voor Stryker Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

18 ratings

16

Buy

2

Hold

0

Sell

Sentiment

By Acuity

262 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.